246047-29-0

Basic information

• Product Name: ((S)-3-Amino-1-benzyl-2-hydroxy-propyl)-carbamic acid tert-butyl ester
• Synonyms: ((S)-3-Amino-1-benzyl-2-hydroxy-propyl)-carbamic acid tert-butyl ester
• CAS NO: 246047-29-0
• Molecular Weight: 280.367
• Mol File: 246047-29-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: ((S)-3-Amino-1-benzyl-2-hydroxy-propyl)-carbamic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: ((S)-3-Amino-1-benzyl-2-hydroxy-propyl)-carbamic acid tert-butyl ester(246047-29-0)
• EPA Substance Registry System: ((S)-3-Amino-1-benzyl-2-hydroxy-propyl)-carbamic acid tert-butyl ester(246047-29-0)

Safety Data

• Hazardous Substances Data: 246047-29-0(Hazardous Substances Data)

Upstream product

• 220871-52-3 1(R,S)-<1'-(S)-<(tert-butyloxycarbonyl)amino>-2-phenylethyl>oxirane 

Downstream Products

• 162539-58-4 [(S)-1-(4-Benzyloxy-benzyl)-3-((S)-3-tert-butoxycarbonylamino-2-hydroxy-4-phenyl-butylamino)-2-hydroxy-propyl]-carbamic acid tert-butyl ester 
• 162539-57-3 {(S)-3-((S)-3-tert-Butoxycarbonylamino-2-hydroxy-4-phenyl-butylamino)-2-hydroxy-1-[4-(2-pyridin-2-yl-ethoxy)-benzyl]-propyl}-carbamic acid tert-butyl ester 
• 162539-95-9 {(S)-3-((S)-3-tert-Butoxycarbonylamino-2-hydroxy-4-phenyl-butylamino)-2-hydroxy-1-[4-(2-methoxy-ethoxy)-benzyl]-propyl}-carbamic acid tert-butyl ester 
• 162540-93-4 {4-[(S)-2-tert-Butoxycarbonylamino-4-((S)-3-tert-butoxycarbonylamino-2-hydroxy-4-phenyl-butylamino)-3-hydroxy-butyl]-phenoxy}-acetic acid 
• 175417-50-2 {(S)-3-((S)-3-tert-Butoxycarbonylamino-2-hydroxy-4-phenyl-butylamino)-2-hydroxy-1-[4-(2-hydroxy-propoxy)-benzyl]-propyl}-carbamic acid tert-butyl ester 
• 162540-97-8 [(S)-3-((S)-3-tert-Butoxycarbonylamino-2-hydroxy-4-phenyl-butylamino)-2-hydroxy-1-(2-hydroxy-benzyl)-propyl]-carbamic acid tert-butyl ester 
• 162538-24-1 [(S)-3-((S)-3-tert-Butoxycarbonylamino-2-hydroxy-4-phenyl-butylamino)-2-hydroxy-1-(3-hydroxy-benzyl)-propyl]-carbamic acid tert-butyl ester 

Relevant articles and documents

Aminodiol HIV protease inhibitors. Synthesis and structure - Activity relationships of P1/P1′ compounds: Correlation between lipophilicity and cytotoxicity

A series of novel aminodiol inhibitors of HIV protease based on the lead compound 1 with structural modifications at P1′ were synthesized in order to reduce the cytotoxicity of 1. We have observed a high degree of correlation between the lipophilicity and the cytotoxicity of this series of inhibitors. It was found that appropriate substitution at the para position of the P1′ phenyl group of 1 resulted in the identification of equipotent (both against the enzyme and in cell culture) compounds (101, 10m, 10n, and 15c) which possess significantly decreased cytotoxicity.